Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy
Figure 3
Inactivation of RASSF2 causes morphology changes. H441 cells stably expressing RASSF2 shRNA constructs and a control shRNA were viewed and photographed using phase contrast at 100x magnification.
